Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

European Market Report for Modern Insulin 2016 - Research and Markets

Research and Markets
Posted on: 30 Sep 16

Research and Markets has announced the addition of the "European Market Report for Modern Insulin 2016 - MedCore" report to their offering.

The European modern insulin market can be segmented by insulin type, yielding three segments: long-acting insulin, rapid-acting insulin and premixed insulin. In 2015, the largest segment in the total modern insulin market was the long-acting insulin segment, which represented nearly 50% of the total market value.

Patent expirations and the introduction of new products will lead to higher unit sales growth in this segment, relative to the rapid-acting insulin and premixed insulin segments. Combined with modest appreciation of ASP, it is projected that long-acting insulin will be the fastest growing segment in the total modern insulin market over the forecast period.

Key Topics Covered:

1. Executive Summary

  • European Market For Diabetes Monitoring, Treatment And Drug Delivery
  • Competitive Analysis
  • Market Trends
  • Market Developments
  • Markets Included
  • Key Report Updates
  • Version History
  • Research Methodology

2. Disease Overview

2.1 Introduction

2.1.1 Types Of Diabetes

2.1.2 Diabetes Complications

2.1.3 Risk Factors Associated With Type 1 And Type 2 Diabetes

2.1.4 Signs And Symptoms

2.1.5 Diabetes Monitoring

2.1.6 Treatment

2.1.7 Drug Delivery Systems

3. Country Profiles

3.1 Introduction

3.1.1 Population

3.1.2 Gdp Per Capita

3.1.3 Units

Modern Insulin Market

4.1 Introduction

4.1.1 Insulin Types Rapid-Acting Insulin Analogs Regular Human Insulin Intermediate-Acting Insulin Analogs Long-Acting Insulin Analogs Ultra-Long-Acting Insulin Analogs

4.2 Market Overview

4.3 Market Analysis And Forecast

4.3.1 Total Modern Insulin Market

4.3.2 Long-Acting Insulin Market

4.3.3 Rapid-Acting Insulin Market

4.3.4 Premixed Insulin Market

4.4 Drivers And Limiters

4.4.1 Market Drivers

4.4.2 Market Limiters

4.5 Competitive Market Share Analysis

Companies Mentioned

  • Novo Nordisk
  • Sanofi
  • Roche
  • Johnson & Johnson
  • Eli Lilly
  • Abbott
  • Ascensia
  • Becton Dickinson
  • Medtronic
  • Menarini
  • DexCom
  • Ypsomed
  • Insulet
  • Artsana
  • B. Braun
  • Terumo

For more information about this report visit

View source version on

Business Wire

Last updated on: 30/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.